Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OriGene Technologies is a global life sciences company that provides a comprehensive suite of products for gene research and drug discovery. The company is recognized for maintaining the world's largest collection of human cDNA clones and purified human proteins, which serve as essential tools for functional genomics. Their portfolio includes high-quality monoclonal antibodies, CRISPR/Cas9 genome editing kits, RNAi reagents, and customized assay development services. By offering genome-wide coverage of biological tools, OriGene supports researchers in academic, biotechnology, and pharmaceutical sectors in their efforts to understand disease mechanisms and identify new therapeutic targets. The company also provides diagnostic grade reagents and has expanded its reach through strategic acquisitions in the antibody and protein sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OriGene Biotech.